Richard completed his PhD at the University of Nottingham before starting a research position in Prof Rita Tewari’s group working in a range of areas from parasite motility to cell division using the malaria model, Plasmodium berghei. He then moved to the University of Dundee to work on mode of action studies for new antiparasitic drugs in the group of Dr Susan Wyllie. This combined a myriad of genetic, proteomic and bioinformatic techniques to identify the target of new treatments against parasites that cause Chagas’ disease, Leishmaniasis, Sleeping Sickness and Malaria. Currently, he leads the lab of Prof Anil Koul at LSHTM with an aim to discover new drugs for the treatment of M. tuberculosis as well as investigating the underlying biology surrounding key drug targets.